A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Clinical trial NCT05010005 · RECRUITING

Trial details

NCT number: NCT05010005
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Lymphomas NK-Cell Lymphomas T-cell Prolymphocytic Leukemia T-cell Large Granular Lymphocyte Leukemia

Start date: 2021-08-12
Primary completion: 2027-08-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.